Jpmorgan Chase & CO Adma Biologics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 782,194 shares of ADMA stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
782,194
Previous 767,265 1.95%
Holding current value
$15.5 Million
Previous $13.2 Million 17.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$15.44 - $20.61 $230,503 - $307,686
14,929 Added 1.95%
782,194 $15.5 Million
Q4 2024

Feb 12, 2025
BUY
$15.62 - $22.62 $8.77 Million - $12.7 Million
561,310 Added 272.54%
767,265 $13.2 Million
Q3 2024

Dec 26, 2024
SELL
$11.21 - $20.03 $377,025 - $673,668
-33,633 Reduced 14.04%
205,955 $4.12 Million
Q3 2024

Nov 08, 2024
SELL
$11.21 - $20.03 $377,025 - $673,668
-33,633 Reduced 14.04%
205,955 $4.12 Million
Q2 2024

Dec 26, 2024
BUY
$5.98 - $11.18 $201,125 - $376,016
33,633 Added 16.33%
239,588 $2.68 Million
Q2 2024

Aug 12, 2024
BUY
$5.98 - $11.18 $195,587 - $365,664
32,707 Added 15.81%
239,588 $2.68 Million
Q1 2024

Dec 26, 2024
BUY
$4.4 - $6.74 $4,074 - $6,241
926 Added 0.45%
206,881 $1.37 Million
Q1 2024

May 10, 2024
BUY
$4.4 - $6.74 $90,257 - $138,257
20,513 Added 11.01%
206,881 $1.37 Million
Q4 2023

Dec 26, 2024
SELL
$3.08 - $4.52 $60,327 - $88,533
-19,587 Reduced 9.51%
186,368 $842,000
Q4 2023

Feb 12, 2024
SELL
$3.08 - $4.52 $2,969 - $4,357
-964 Reduced 0.51%
186,368 $842,000
Q3 2023

Nov 14, 2023
BUY
$3.47 - $4.61 $41,286 - $54,849
11,898 Added 6.78%
187,332 $670,000
Q2 2023

Aug 11, 2023
BUY
$3.12 - $4.22 $3,775 - $5,106
1,210 Added 0.69%
175,434 $647,000
Q1 2023

May 18, 2023
BUY
$3.01 - $3.87 $482,767 - $620,701
160,388 Added 1159.21%
174,224 $576,000
Q1 2023

May 11, 2023
SELL
$3.01 - $3.87 $815,926 - $1.05 Million
-271,072 Reduced 95.14%
13,836 $45,000
Q4 2022

Feb 13, 2023
BUY
$2.47 - $3.88 $432,032 - $678,658
174,912 Added 159.02%
284,908 $1.11 Million
Q3 2022

Nov 14, 2022
BUY
$2.03 - $2.86 $3,861 - $5,439
1,902 Added 1.76%
109,996 $268,000
Q2 2022

Aug 11, 2022
BUY
$1.43 - $2.2 $41,452 - $63,773
28,988 Added 36.64%
108,094 $214,000
Q1 2022

May 11, 2022
BUY
$1.28 - $1.83 $79,243 - $113,293
61,909 Added 360.0%
79,106 $144,000
Q4 2021

Feb 10, 2022
BUY
$1.09 - $1.66 $18,744 - $28,547
17,197 New
17,197 $24,000

Others Institutions Holding ADMA

# of Institutions
379
Shares Held
188M
Call Options Held
2.53M
Put Options Held
696K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.9B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email